Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Illumina, Inc. - Common Stock (NQ: ILMN )

136.02 +2.02 (+1.51%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
29 30 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash. 
Via Benzinga
Illumina, Inc. (NASDAQ: ILMN) is a Leading Gainer in Monday Morning Trading
Via Investor Brand Network
Why Illumina Shares Are Soaring Today?
Via Benzinga
A Look Into Illumina's Debt
Via Benzinga
How Is The Market Feeling About Illumina?
Via Benzinga
Illumina Surges As Activist Carl Icahn Reportedly Steps In Over Grail
Icahn is reportedly planning a proxy fight with Illumina, frustrated by the Grail efforts. 
Via Investor's Business Daily
Illumina, Seagen And Other Big Stocks Moving Higher On Monday
U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Is ROKU Stock Down Today?
Roku (ROKU) stock is taking a beating on Monday after it was revealed a large portion of the company's funds were held at Silicon Valley Bank. 
Via InvestorPlace
ILMN Stock Alert: What to Know as Carl Icahn Prepares for Proxy Fight With Illumina
Illumina (ILMN) stock is a hot topic among traders on Monday as reports claim Carl Icahn is gearing up for a proxy fight. 
Via InvestorPlace
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis. 
Via Benzinga
DNA-Reading Giant Illumina Topples On Wide Profit Miss
Sales narrowly topped expectations, however. 
Via Investor's Business Daily
Church & Dwight, A. O. Smith, Illumina And This US Bank Are CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Joseph Terranova of Virtus Investment Partners said Church & Dwight Co., Inc. (NYSE: CHD) has consolidated the recent gains and is likely 
Via Benzinga
DNA Sequencing and Service Market May See a Big Move : Abbott Laboratories, Eurofins Scientific, Illumina
Stay up-to-date with DNA Sequencing and Service Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Strategic partnership offers a unique combination of diagnostic development and commercialization capabilities to the pharmaceutical industry 
From Myriad Genetics, Inc.
Via GlobeNewswire
If You Invested $100 In This Stock 10 Years Ago, You Would Have $400 Today
Via Benzinga
Earnings Preview For Illumina
Via Benzinga
7 Analysts Have This to Say About Illumina
Via Benzinga
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks
Startling cancer vaccine results from Moderna may point to the next big thing in biotech. 
Via Investor's Business Daily
Home Healthcare Equipment Market Trends, Volume, Growth Strategies Forecast Report 2023
Some of the major players profiled in the Home Healthcare Equipment Market report are Abbott Laboratories (US), F. Hoffman-La Roche (Switzerland), QIAGEN (Germany), Thermo Fisher Scientific (US),... 
Via SBWire
Topics Economy
Exposures Supply Chain
Cri-Du-Chat Syndrome Market Demand Trends Size Overview Analysis 2022-2029
Global Cri-du-chat Syndrome Market to Witness Huge Growth by Key Players: Centogene AG, Eurofins Scientific, Laboratory Corporation of America Holdings, Quest Diagnostics, PerkinElmer Inc., Natera,... 
Via SBWire
7 Stocks to Buy and Hold for the Next 20 Years
When choosing stocks to buy and hold for the next 20 years, pick companies with strong comparative advantages in durable sectors. 
Via InvestorPlace
Cramer Likens This Stock To 'A Fine Merlot': It's Down 1% In 2023, So 'I Would Buy All You Can Right Here'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Parker-Hannifin Corp (NYSE: PH) is "just the kind of industrial I’ve been recommending." 
Via Benzinga
New Survey Data Shows Innovation Teams at Large Companies Are Focusing More on Near-Term Initiatives, but Internal Politics and Culture Remain Top Challenges
InnoLead has released a 2023 update to its popular Benchmarking Innovation Impact research with KPMG LLP. 
Via Newswire.com
US Stocks Pause Ahead Of Powell's Speech: Analyst Warns Of Retest Of October Lows As Market, Economic Data Conspire Against Monetary Policy
Stocks look set for another nervous session on Tuesday as traders look ahead to comments from Fed Chair Jerome Powell and another batch of earnings reports. Cues From Monday’s Trading: 
Via Benzinga
Catalent Hits Four-Month High As Danaher Reportedly Mulls A Takeover
Danaher is reportedly looking to add to its wheelhouse to compete with Thermo. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023
Via Benzinga
Healthcare Sector Is Lagging As We Enter 2022 Earnings Season
The healthcare sector is perceived as defensive but in 2023 there is more investor appetite for risk based on the QQQ comeback and the XBI strength. 
Via Talk Markets
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
Universal Sequencing Technology Corporation (UST) partners with TATAA Biocenter to offer Long Read Sequencing Services with TELL-Seq Linked-Read Tech
CARLSBAD, Calif. - Jan. 10, 2023 - PRLog -- Universal Sequencing Technology Corporation (UST) announces today, January 10th, 2022, that it has partnered with TATAA Biocenter, one of our key... 
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.